Atlas Trials

Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell Transplantation

Clinical trial NCT04886206 · UNKNOWN

Trial details

NCT number
NCT04886206
Sponsor
Nantes University Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid Leukemia (AML)
Start date
2021-11-10
Primary completion
2024-11-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.